India reported 4,01,078 coronavirus cases on Saturday with the record high deaths of 4,187 in the last 24 hours to 8:00 AM. This is also the third straight day when the country reported more than 4-lakh daily cases in a single day. On a cumulative basis, the Covid infections stood at 2,18,92,676 of which active cases were 37,23,446, those who recovered stood at 1,79,30,960 and the death toll was 2,38,270.
Meanwhile, India administered 16,73,46,544 anti-covid jabs so far of which 22,97,257 shots were given in a single day till 8:00 AM on Saturday. As per the Health Ministry website, India conducted 18,08,344 tests in the previous day.
Besides this, the government has sent the company-wise supply plan of Remdesivir for the period of April 21-May 16. It has allocated the supply plan among Zydus Cadilla, Hetero, Mylan, Cipla, Syngene/Sun, Jubilant and Dr Reddy’s. The companies have been instructed to ensure timely supplies to all states/UTS strictly as per supply plan. India currently has only seven manufacturers of Remdesivir.
On Friday, the government increased the allocation of the drug to 53 lakh vials (from 34.5 lakh earlier) up to May 16, in continuation of the previous plan from April 21-May 9. Maharashtra would get the highest share of 11.57 lakh vials, followed by Karnataka (5.75 lakh) and Uttar Pradesh (4.95 lakh).
Allocation of 53 lakh vials of Remdesivir Zydus Cadilla 9,82,100 Hetero 17,17,050 Mylan 7,28,000 Cipla 7,32,300 Syngene/Sun 3,73,000 Jubillant 4,45,700 Dr Reddy’s 3,21,850